Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.2700 (-2.13%) ($14.2100 - $15.0000) on Wed. Jul. 31, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.1% (three month average) | RSI | 17 | Latest Price | $14.2700(-2.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.05% in a week (0% probabilities). VXX(-35%) VIXM(-35%) TLT(-13%) UNG(-7%) IFRA(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.05% (StdDev 4.1%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
1 - 5 Day Possible Target | $-6.92(-148.49%) | Resistance Level | $16.32 | 5 Day Moving Average | $14.51(-1.65%) | 10 Day Moving Average | $14.77(-3.39%) | 20 Day Moving Average | $16.32(-12.56%) | To recent high | -60.6% | To recent low | 0.1% | Market Cap | $1.06b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |